Cihan Ay and RIETE Investigators Team Present External Validation of the VTE-PREDICT Score
Journal of Thrombosis and Haemostasis (JTH) shared on LinkedIn:
”External validation of the VTE-PREDICT score for predicting recurrence and bleeding in venous thromboembolism: results from the RIETE Registry
By Timothy Hoberstorfer, Stephan Nopp, Daniel Steiner, Jaime Luis Blasco Hernandez, Inés Jou, Juan José López-Núñez, Ángeles Fidalgo, Patricia López Miguel, Manuel Monreal, and Cihan Ay
— On behalf of the RIETE Investigators
• The VTE-PREDICT score was designed to estimate recurrence and bleeding risks after acute VTE, but required validation in real-world populations.
• In 17 850 patients (median age 67 years; 64% with PE) from the RIETE registry, the model’s performance was tested for outcomes over 1–5 years under varied anticoagulant regimens.
• The score showed good discrimination for recurrence (c = 0.70–0.73) and moderate for bleeding (c = 0.65–0.67) but underestimated recurrence and overestimated bleeding in high-risk patients. Calibration refinement may enhance its clinical utility.”
Read the full article in JTH.
Article: External validation of the VTE-PREDICT score for predicting recurrence and bleeding in venous thromboembolism: results from the Registro Informatizado Enfermedad TromboEmbὀlica Registry
Authors: Timothy Hoberstorfer, Stephan Nopp, Daniel Steiner, Luis Hernández-Blasco, Inés Jou, Juan José López-Núñez, Ángeles Fidalgo, Patricia López-Miguel, Manuel Monreal, Cihan Ay
Stay updated on all scientific advances in the field of thrombosis with Hemostasis Today.
-
May 6, 2026, 11:50Natalie L. Baggio: A 24/7 Neurointerventional Stroke Care at Corewell Health Is Now a Reality
-
May 6, 2026, 11:30Paula Caporal: Consensus on the Diagnosis and Management of Pediatric Stroke in Argentina
-
May 6, 2026, 11:14Li Khim Kwah: Proud for the Development of The New Singapore Stroke Rehabilitation Guideline
-
May 6, 2026, 10:55Hugo Antonio Romo Rubio: A New Paradigm in Treatment for Hemophilia A from FRONTIERS2 Phase 3 Study
-
May 6, 2026, 10:40Ifeanyichukwu Ifechidere: Why INR Can Be Dangerously Misleading
-
May 6, 2026, 02:58Limiaa Babikir: What Is Polyspecific DAT?
-
May 6, 2026, 02:47Karen Rollinson: Connecting with so Many Families and Advocates at HFA 2026
-
May 6, 2026, 02:38Moustafa Abdou: Is the Bone Marrow Examination Still the ‘Gold Standard’?
-
May 6, 2026, 02:23Khaled Musallam: When the Worlds of Thalassemia and Hemophilia Converge